Author

Kim K. Vettenranta

University of HelsinkiORCID 0000-0002-8535-0135Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell-cell communication· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Erja KerkeläiD· 3 shared Farhana JahaniD· 3 shared Seppo Ylä-HerttualaiD· 3 shared Diana SchenkweiniD· 2 shared Emmi JärveläiD· 2 shared Helka GöösiD· 2 shared Henrik PaavilaineniD· 2 shared Jan KoskiiD· 2 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Erja KerkeläORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Efficient NK cell transduction with VSV-G-pseudotyped lentiviral vectors

Emmi Järvelä, Jan Koski, Farhana Jahan, Antti Tuhkala, Mira Saari, Manar Elmadani, Kari Salokas, Laurens Veltman, Lotta Andersson, Erja Kerkelä, Hekim Can, Marie C. Nyman, Seppo Ylä-Herttuala, Markku T Varjosalo, Diana Schenkwein, , Helka Göös

This study optimizes VSV-G-pseudotyped lentiviral transduction of NK cells by improving activation, construct design, and enhancer use, achieving high efficiency without compromising cell function.

Molecular Therapy Advances · May 5, 2026Peer-reviewedImmunology

Feeder cell - the key component in producing scalable and fit NK cells for therapeutic use

Mira Saari, Farhana Jahan, Lotta Andersson, Anna Syreeni, Pirjo Vehmaan-Kreula, Jan Koski, Emmi Järvelä, Erja Kerkelä, Henrik Paavilainen, Diana Schenkwein, Seppo Ylä-Herttuala, Kim K. Vettenranta, Helka Göös, Matti Korhonen

This study evaluates engineered K562 feeder cells for enhancing NK cell expansion and function in ex vivo cultures, showing up to 500-fold higher yields compared to feeder-free systems.

bioRxiv · Apr 23, 2026 · PreprintImmunology

Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts

Farhana Jahan, Leena Penna, Annu Luostarinen, Laurens Veltman, Heidi Hongisto, Kaarina Lähteenmäki, Sabine Müller, Seppo Ylä‐Herttuala, Matti O. Korhonen, Kim K. Vettenranta, Anita Laitinen, Urpu Salmenniemi, Erja Kerkelä

This paper describes a GMP-compliant protocol for producing potent NK cells against AML and neuroblastoma using an automated platform, showing increased activation and killing efficacy.

Scientific Reports · Nov 4, 2024Peer-reviewedImmunology